Who
Nir Livneh
VP, General Counsel
Company insider
Files Form 4 as: VP, General Counsel, Kamada.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Apr 2026
- Last trade
- 14 Sep 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 17 Sep 2026 | KMDA KamadaBiotechnology | SEC FORM 4 Code M | $54K10,000 at $5.37 | filing |
| 14 Sep 2026filed 17 Sep 2026 | KMDA KamadaBiotechnology | SEC FORM 4 Code F | $29K3,459 at $8.35 | filing |
| 14 Sep 2026filed 17 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | KMDA KamadaBiotechnology | SEC FORM 4 Code M | $54K10,000 at $5.37 | filing |
| 14 Sep 2026filed 17 Sep 2026 | KMDA KamadaBiotechnology | SEC FORM 4 Code F | $29K3,459 at $8.35 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,485 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,485 at $0.00 | filing |
| 27 Aug 2026filed 23 Sep 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,485 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code D | —9,485 | filing |
| 7 Apr 2026filed 9 Apr 2026 | KMDA Kamadaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.